Furthermore, the combination of curcumin with PD-L1 blockers or CTLA-4 blockers may have a synergistic effect compared to monotherapy, further inhibiting tumor growth, promoting T-cell activation, inhibiting Treg infiltration, and dramatically improving TME. The gene discussed is CTLA4; the disease is neoplasm.